Tim Frank Andersen on stage in front of a large conference audience

Keynote speaker & moderator on AI and technology

Tim FrankAndersen

I’ve worked in tech for 30 years. Right now the big shift is AI
- I help organisations understand what’s real, what’s next, and what’s in it for them.

Today’s AI news, every morning

Free. No spam. Easy to unsubscribe.
Read today’s news →

Today in AI
  • Nvidia builds a cage for runaway AI agents
  • Anthropic's IPO papers show a $518 billion bet
  • AMD pays $8.2 billion for AI that understands the physical world
  • Roche wants AI in on 80 per cent of its research bets
  • China makes AI bosses' families ask permission to travel

About

Tim Frank Andersen

Thirty years in tech - from founding one of Denmark’s first digital agencies to co-founding institute of AI. Author, tech expert on TV, and advisor to some of the world’s biggest brands.

More about Tim →

Speaking

Two ways to book Tim

See speaking →

Format 01

Keynote - The AI Explosion

What’s real, what’s next, and what’s in it for you. Live demos, honest answers, and a look at the next 12-24 months, which will change our world.

Format 02

Moderator

The person tying it all together - sharp questions and a clear thread through your conference.

What organisers say

Rated 5.0 from 11 reviews.

“I’ve heard plenty of talks about AI, and never found it more captivating or relevant than yours.”

Rikke Ekelund

“He inspired us all. Not a generic set of examples, but real, recent insight - told with genuine care for the work we do.”

Marc Amin

“Thank you for an extremely exciting talk - on a topic every company will relate to. Exciting to think about where we’ll be in 5 years: we must see opportunities, not limitations.”

Gitte Taulov Rude, Senior Business Advisor, Danske Bank

Updated every day

Today in AI - 5 curated news stories that matter

Curated by Tim, every morning.

Today · 29 Sept 2026
  1. 01

    Nvidia builds a cage for runaway AI agents

    For weeks, AI agents, programs that carry out tasks on their own, have kept wandering where they should not: into a Medicare portal, onto government websites, out of OpenAI's own test lab. Yesterday Nvidia launched its answer. Free software fences each agent in. A separate watchdog runs on its own Nvidia chip, watches the agent from outside and can quarantine it within milliseconds. The agent cannot see the watchdog, so it cannot switch it off. More than 100 companies, including Anthropic, Microsoft and SAP, signed on at launch. The fence is free, but the watchdog only runs on Nvidia's chips, so the strongest version of agent safety now comes with a hardware bill.

  2. 02

    Anthropic's IPO papers show a $518 billion bet

    We finally get to look inside one of the big AI labs. Anthropic, the company behind Claude, has filed papers for a stock market listing, and Reuters has seen them. The headline figure is a loss of $42 billion last year, though most of that is a one-off accounting charge tied to how the company raised money. The number I would stare at is another one: $518 billion promised to cloud and computing suppliers over the coming years, more than 100 times last year's revenue. The listing is expected after the US midterm elections in November. Buying the shares means betting that demand keeps compounding too.

  3. 03

    AMD pays $8.2 billion for AI that understands the physical world

    Chatbots learned from text. The next wave of AI has to learn how rooms, streets and objects behave, so robots and self-driving cars can move through them. AMD, Nvidia's main rival in AI chips, is buying World Labs, one of the leading startups building exactly that kind of AI, for $8.2 billion in shares. World Labs' co-founder Fei-Fei Li, often called the godmother of AI, becomes AMD's chief scientist. I see AMD buying a seat where tomorrow's chips get designed, because whoever first understands what the new AI needs from a chip can build that chip first. That is roughly how Nvidia got ahead.

  4. 04

    Roche wants AI in on 80 per cent of its research bets

    Deciding which drugs to back is the most expensive call a pharma company makes. At its investor day yesterday, Roche, the Swiss drug giant, said AI or computer modelling played a documented part in 40 per cent of its recent pipeline decisions. By year end it wants its own AI tool involved in 80 per cent of research funding decisions. Roche also says its late-stage trials succeed more often this year, though nobody can yet show how much of that is the AI. Novo Nordisk, the Danish maker of Wegovy, signed an AI deal with Anthropic earlier this month. Expect investors to ask other drugmakers how many of their decisions AI touched.

  5. 05

    China makes AI bosses' families ask permission to travel

    Spouses and children of top executives at Chinese AI and chip companies, including Alibaba and DeepSeek, now need government approval to travel abroad, even briefly, according to Bloomberg. The executives themselves have needed it since May. The aim, Bloomberg reports, is to keep know-how from reaching America. Meta's collapsed bid for Manus, a Chinese-founded startup that builds AI agents, raised the worry, though the rule is not necessarily a response to it. Imagine running a company where your family's holiday needs a ministry's stamp. For Western companies hoping to hire from, or partner with, China's AI labs, that door is closing.

Want to stay updated on AI in your inbox?

Free, every morning. No spam, unsubscribe anytime.

Book Tim to speak

Book Tim →